The FDA Group's Insider Newsletter

The FDA Group's Insider Newsletter

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
4 Best Practices for Preventing CRLs in Biologics Manufacturing
Copy link
Facebook
Email
Notes
More

4 Best Practices for Preventing CRLs in Biologics Manufacturing

Coinciding with more BLAs in recent years, CDER is handing out more CRLs related to manufacturing issues. Here are a few ways to prevent one yourself.

The FDA Group's avatar
The FDA Group
Aug 27, 2024
∙ Paid

Share this post

The FDA Group's Insider Newsletter
The FDA Group's Insider Newsletter
4 Best Practices for Preventing CRLs in Biologics Manufacturing
Copy link
Facebook
Email
Notes
More
Share

A new report in RAPS sheds light on the increase in BLAs coupled with a rise in CRLs issued by the CDER. CDER Director Patrizia Cavazzoni presented this information at a meeting on biologics and bios…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The FDA Group, LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More